Abivax AAVXF
NASDAQ AAVXF
$139.00 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Abivax (AAVXF) Other Non-Current Assets (2022 - 2025)

Abivax (AAVXF) posted Other Non-Current Assets of $727527.2 for Q4 2025, down 19.39% on a QoQ basis from $902516.8 in Q1 2025, and down 28.18% year-over-year from $1.0 million in Q4 2024.

Analysis

Abivax (AAVXF) Other Non-Current Assets (2022 - 2025) Analysis & Trends

Abivax has reported Other Non-Current Assets for 4 years, with the latest figure at $727527.2 in Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 28.18% year-over-year to $727527.2 in Q4 2025; TTM through Dec 2025 was $727527.2, a 28.18% decrease from a year earlier, with the FY2025 full-year figure at $727527.2, down 28.18% from the prior year.
  • Other Non-Current Assets was $727527.2 for Q4 2025 at Abivax, down from $902516.8 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.5 million in Q4 2023, with the low at $727527.2 in Q4 2025.
  • Average Other Non-Current Assets over 4 years is $1.2 million, with a median of $1.0 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 135.93% in 2023, then tumbled 59.42% in 2024.
  • Over 4 years, Other Non-Current Assets stood at $1.1 million in 2022, then surged by 135.93% to $2.5 million in 2023, then tumbled by 59.42% to $1.0 million in 2024, then slipped by 28.18% to $727527.2 in 2025.
  • The last three Other Non-Current Assets figures came in at $727527.2 (Q4 2025), $902516.8 (Q1 2025), and $1.0 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn 29.59 Mn
10 Abivax 10.92 Bn 10.92 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 727,527.20
Mar 31, 2025 902,516.85
Dec 31, 2024 1.01 Mn
Jun 30, 2024 1.21 Mn
Dec 31, 2023 2.50 Mn
Dec 31, 2022 1.06 Mn